Stay updated on Pembrolizumab for Advanced Uveal Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The record presents details of a terminated Phase II pembrolizumab study for advanced uveal melanoma, including its study design, eligibility criteria, outcomes, locations, and investigators.
    Difference
    53%
    Check dated 2026-11-10T14:54:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.2 to v3.8.0. The study record remains unavailable because the page displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T15:53:21.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces the transition from “Artificial Intelligence” to “Super Intelligence” terminology under Executive Order 14434. The site revision label also changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T16:55:32.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The site footer revision marker changes from v3.7.0 to v3.7.1; the study page continues to display a 403 Forbidden message.
    Difference
    0.2%
    Check dated 2026-10-06T18:22:01.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error screen with a minimal header and a Home button, replacing the previous study details and navigation. This indicates an access-denied state rather than an update to the study information.
    Difference
    19%
    Check dated 2026-09-22T21:48:25.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.7.0, replacing Revision: v3.6.6. This reflects a system update rather than changes to the study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:35:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Advanced Uveal Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Advanced Uveal Melanoma Clinical Trial page.